secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2023-04-21T23:59:59+00:00
Accession:  0001104659-23-048405
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRX Pharma receives Nasdaq bid price deficiency notice; sues to unmask short attackers
--------------------------------------------------------------------------------

- Nasdaq notice on April 18, 2023: closing bid below $1.00 for 30 consecutive business days.
- Company has 180 days (until Oct 16, 2023) to regain compliance; needs $1.00+ close for 10 days.
- Filed NY State Supreme Court lawsuit to compel disclosure of identities posting false, derogatory info.
- Commissioned expert counsel to assess impact of naked shorting and spoofing on stock.
- Confirms strategic licensing discussions remain ongoing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000110465923048405/0001104659-23-048405-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000110465923048405/tm2313427d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-048405

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer